Tag Archives: First

Lilly’s Cyramza (ramucirumab) Becomes First FDA-Approved Biomarker-Driven Therapy in Patients with Hepatocellular Carcinoma

Print this page INDIANAPOLIS, May 13, 2019 /PRNewswire/ — Eli Lilly and Company (NYSE: LLY) today announced that the U.S. Food and Drug Administration (FDA) has approved Cyramza (ramucirumab injection, 10 mg/mL solution), as a single agent, for the treatment of patients with hepatocellular carcinoma (HCC) who have an alpha-fetoprotein (AFP) of ≥400 ng/mL and… Read More »

First Edition: April 24, 2019

Today’s early morning highlights from the major news organizations Kaiser Health News: Amid Opioid Prescriber Crackdown, Health Officials Reach Out To Pain Patients A pharmacist in Celina, Tenn., was one of 60 people indicted on charges of opioid-related crimes last week, in a multistate sting. John Polston was charged with 21 counts of filling medically unnecessary narcotic… Read More »

First man to sign up for head transplant bows out, but surgeon insists list of volunteers is still ‘quite long’

Having fallen head over heels in love, the first volunteer for a human head/body transplant has pulled out, saying he could not leave his new wife and baby boy for the months that surgery surely would have required. Valery Spiridonov, a 33-year-old Russian computer scientist who suffers from a devastating muscle wasting disease that has… Read More »